This document stipulates the environment, facilities and personnel, equipment, reagents and consumables, sample collection, inspection procedures, and quality assurance requirements for new coronavirus nucleic acid point-of-care testing. This document is applicable to all types of medical and health institutions at all levels that carry out point-of-care testing of novel coronavirus nucleic acid.
T/CAME 57-2023 history
2023T/CAME 57-2023 Code of practice for point-of-care testing of SARS-CoV-2 nuclei acid